Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06870812 · ClinicalTrials.gov registry record · NA

Rapid Evacuation and Access of Cerebral Hemorrhage Trial

A NA study of Stroke Hemorrhagic, sponsored by Emory University.

Recruiting
Registry status
NA
Development phase
600
Enrollment target
20
Study locations

NCT06870812 is a NA study of Stroke Hemorrhagic that is actively recruiting participants, run by Emory University. The registered enrollment target is 600 participants, above the 56-participant average among 6 other Stroke Hemorrhagic trials with a reported enrollment target (971% higher). The trial reports 20 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06870812, a NA study of Stroke Hemorrhagic, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
NA
Development phase
600 participants
Enrollment target
20
Study locations

Study Summary

The main purpose of this study is to compare patients with a deep bleed in the brain undergoing surgery to patients receiving routine medical care. The standard treatment involves admission to the Intensive Care Unit (ICU) with close monitoring and blood pressure control. It also includes other medical (non-surgical) treatments to prevent more bleeding or another stroke. Sometimes, doctors will recommend surgery to remove the blood if medical treatment alone is not successful. There is evidence that doing minimally invasive surgery early-using a small opening in the skull to remove blood-may help some patients. Researchers aim to understand whether this surgery is better than current medical treatment, which may include surgeries to relieve pressure on the brain in some cases. This study, called REACH, is comparing usual medical care to early minimally invasive surgery so doctors can know which is better for patients.

Conditions Studied

Stroke Hemorrhagic

Interventions

  • OTHER Medical Management
  • PROCEDURE Surgical management

Study Locations (20)

Florida

  • Baptist Health Jacksonville FL - Jacksonville
  • Baptist Health South Florida - Kendall
  • Jackson Memorial Hospital (JMH) - Miami

Georgia

  • Grady Memorial Hospital - Atlanta
  • Emory Hospital Midtown - Atlanta
  • Emory University Hospital (EUH) - Atlanta

New York

  • Albany Medical Center - Albany
  • SUNY Upstate Medical University - Syracuse
  • Montefiore Medical Center/Albert Einstein School of Medicine - The Bronx

Illinois

  • Rush University - Chicago
  • Endeavor Health, Northshore - Evanston

Ohio

  • The Ohio State University - Columbus
  • ProMedica Toledo Hospital - Toledo

Arkansas

  • University of Arkansas for Medical Sciences - Little Rock

California

  • Stanford University Medical Center - Palo Alto

Indiana

  • Goodman Campbell Brain and Spine - Carmel

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2025-05-27
Est. Completion 2030-03
Phase NA

Sponsor

Emory University

1,208 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06870812

The ClinicalTrials.gov registry entry for NCT06870812 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 56-participant average among 6 other Stroke Hemorrhagic trials with a reported enrollment target (971% higher). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke Hemorrhagic appearing as the primary indexed condition, and to 2 interventions - of which Medical Management is the first listed.

NCT06870812 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Florida, Georgia, New York.

Frequently Asked Questions

What is clinical trial NCT06870812 about?

NCT06870812 is a clinical study titled "Rapid Evacuation and Access of Cerebral Hemorrhage Trial". The main purpose of this study is to compare patients with a deep bleed in the brain undergoing surgery to patients receiving routine medical care. The standard treatment involves admission to the Intensive Care Unit (ICU) with close monitoring and blood pressure control. It also includes other medi...

What is the current status of trial NCT06870812?

This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2025-05-27. Estimated completion is 2030-03.

What conditions does trial NCT06870812 study?

This clinical trial studies the following conditions: Stroke Hemorrhagic.

What interventions are being tested in trial NCT06870812?

The interventions under investigation include: Medical Management (OTHER), Surgical management (PROCEDURE).

Who is sponsoring clinical trial NCT06870812?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06870812 being conducted?

This trial has 20 study locations across Arkansas, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Stroke Hemorrhagic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Stroke Hemorrhagic

All registered trials for this condition

Arkansas

All trials with a study site in Arkansas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.